Dyne Therapeutics, Inc Earnings

Dyne Therapeutics, Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its revenue since last 3-months.

Dyne Therapeutics, Inc’s net profit fell -70.28% since last year same period to $-110.86Mn in the Q2 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated 3.9% jump in its net profits since last 3-months.

Dyne Therapeutics, Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its net profit margins since last 3-months.

Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.86 - a 8.67% jump from last quarter’s estimates.

Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current year stand at -0.86.

Dyne Therapeutics, Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Dyne Therapeutics, Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.